Back to funds

Bain Capital Life Sciences Investors, LLC

Updated 6 days ago

Managed by Bain Capital Life Sciences Investors, Llc • Latest filing Q3 2026

Portfolio value
$1.5B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$1.3B
Q1 2026$1.1B
Q2 2026$1.7B
Q3 2026$1.5B

Top holdings

23 positions as of Q3 2026

View filing
K

KAILERA THERAPEUTICS INC

Value
$257.9M
Shares
22.58M
% Port
17.31%
H

HEARTFLOW INC

Value
$221.3M
Shares
4.45M
% Port
14.85%
A

ADARX PHARMACEUTICALS INC

Value
$134.2M
Shares
6.73M
% Port
9.01%
A

ALKERMES PLC

Value
$127.7M
Shares
3.15M
% Port
8.57%
N

NEWAMSTERDAM PHARMA COMPANY

Value
$92.6M
Shares
3.81M
% Port
6.21%
S

SAVARA INC

Value
$90.8M
Shares
17.60M
% Port
6.10%
T

TARSUS PHARMACEUTICALS INC

Value
$86.2M
Shares
1.10M
% Port
5.78%
P

PHARVARIS N V

Value
$76.9M
Shares
2.48M
% Port
5.16%
S

SOLID BIOSCIENCES INC

Value
$70.9M
Shares
9.81M
% Port
4.76%
O

OLEMA PHARMACEUTICALS INC

Value
$61.2M
Shares
7.09M
% Port
4.11%
C

HEMAB THERAPEUTICS HOLDINGS INC

Value
$50.9M
Shares
1.65M
% Port
3.42%
C

CABALETTA BIO INC

Value
$40.7M
Shares
21.21M
% Port
2.73%
F

FREENOME INC

Value
$37.3M
Shares
2.37M
% Port
2.50%
D

DYNE THERAPEUTICS INC

Value
$30.6M
Shares
1.90M
% Port
2.05%
B

C4 THERAPEUTICS INC

Value
$23.9M
Shares
7.17M
% Port
1.60%
?
16.N/A

X4 PHARMACEUTICALS INC

Value
$23.1M
Shares
7.97M
% Port
1.55%
A

ANNEXON INC

Value
$18.8M
Shares
4.44M
% Port
1.26%
A

ATEA PHARMACEUTICALS INC

Value
$10.8M
Shares
2.08M
% Port
0.73%
I

DISC MEDICINE INC

Value
$9.2M
Shares
141.2K
% Port
0.62%
?
20.N/A

KYVERNA THERAPEUTICS INC

Value
$8.9M
Shares
1.31M
% Port
0.60%

Explore